JACQUELINE WYNN: Open Payments
NPI 1609131978 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,150 in 58 payments from 20 companies in 2025. Trend: 2023 $230 · 2024 $769 · 2025 $1,150
Food & beverage: $1,150
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $224 |
| Novo Nordisk Inc | 9 | $165 |
| Exact Sciences Corporation | 4 | $88 |
| Amgen Inc. | 5 | $87 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $81 |
| Astellas Pharma US Inc | 4 | $73 |
| PFIZER INC. | 4 | $72 |
| Esperion Therapeutics, Inc. | 3 | $63 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
Products named: VRAYLAR, UBRELVY, The Cologuard Plus Collection Kit, Kerendia, Ozempic, Veozah, NEXLETOL, ELIQUIS.
Industry payments across FL — which companies pay providers there.
